title: Diagnosis and Management of Hereditary Sarcoma.
abstract: Sarcomas are rare and heterogeneous diseases that affect a younger population than most epithelial cancers. Epidemiologic studies suggest a strong genetic component to sarcomas, and many familial cancer syndromes have been described, in which sarcomas are a feature. The best known of these are the Li-Fraumeni and retinoblastoma syndromes, study of which has been pivotal to elucidating the molecular basis for the cell response to DNA damage and the cell division. Although much has been learnt about cancer biology from the study of sarcoma families, in general clinical management of increased sarcoma risk has lagged behind other cancer predisposition syndromes. With the advent of genomic tools for genetic testing, it is likely that a substantial fraction of sarcoma patients will be identified as carriers of known risk alleles. The translation of this knowledge into effective risk management programs and cancer treatments will be essential to changes in routine clinical practice.
authors.affiliation: The Kinghorn Cancer Centre & Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. d.thomas@garvan.org.au.
authors.forename: David M
authors.initials: DM
authors.lastname: Thomas
authors.affiliation: The Kinghorn Cancer Centre & Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
authors.forename: Mandy L
authors.initials: ML
authors.lastname: Ballinger
mesh_terms: D020022:Genetic Predisposition to Disease; D006801:Humans; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*
keywords: Genetics; Genomics; Sarcoma; TP53